BioGend Therapeutics Co., Ltd. (TPEX:6733)
24.90
-0.20 (-0.80%)
Jun 18, 2026, 1:30 PM CST
-18.49% (1Y)
| Market Cap | 3.10B -12.9% |
| Revenue (ttm) | 229.81M +28.0% |
| Net Income | -67.11M |
| EPS | -0.55 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 172,663 |
| Open | 25.10 |
| Previous Close | 25.10 |
| Day's Range | 24.85 - 25.35 |
| 52-Week Range | 24.85 - 49.15 |
| Beta | 0.09 |
| Analysts | Buy |
| Price Target | 49.00 (+96.79%) |
| Earnings Date | Aug 7, 2026 |